| Year |
Citation |
Score |
| 2013 |
Usha L, Rao G, Christopherson K, Xu X. Mesenchymal Stem Cells Develop Tumor Tropism but Do Not Accelerate Breast Cancer Tumorigenesis in a Somatic Mouse Breast Cancer Model Plos One. 8. PMID 24069135 DOI: 10.1371/Journal.Pone.0067895 |
0.331 |
|
| 2012 |
Jagan S, Paganessi LA, Frank RR, Venugopal P, Larson M, Christopherson KW. Bone Marrow and Peripheral Blood AML Cells Are Highly Sensitive to CNDAC, the Active Form of Sapacitabine. Advances in Hematology. 2012: 727683. PMID 23049558 DOI: 10.1155/2012/727683 |
0.403 |
|
| 2012 |
Christopherson KW, Frank RR, Jagan S, Paganessi LA, Gregory SA, Fung HC. CD26 protease inhibition improves functional response of unfractionated cord blood, bone marrow, and mobilized peripheral blood cells to CXCL12/SDF-1. Experimental Hematology. 40: 945-52. PMID 22846168 DOI: 10.1016/J.Exphem.2012.07.009 |
0.48 |
|
| 2012 |
Broxmeyer HE, Christopherson K, Hangoc G, Cooper S, Mantel C, Renukaradhya GJ, Brutkiewicz RR. CD1d expression on and regulation of murine hematopoietic stem and progenitor cells. Blood. 119: 5731-41. PMID 22535665 DOI: 10.1182/Blood-2012-01-404012 |
0.485 |
|
| 2012 |
McNulty MA, Virdi AS, Christopherson KW, Sena K, Frank RR, Sumner DR. Adult stem cell mobilization enhances intramembranous bone regeneration: a pilot study. Clinical Orthopaedics and Related Research. 470: 2503-12. PMID 22528386 DOI: 10.1007/S11999-012-2357-9 |
0.388 |
|
| 2012 |
Christopherson KW. PBSCs Sphingoling along S1P/S1P1 axis. Blood. 119: 645-6. PMID 22262738 DOI: 10.1182/Blood-2011-11-391250 |
0.354 |
|
| 2012 |
Nathan S, Maciejewski JJ, Rich ES, Venugopal P, Christopherson KW, Gregory SA, Fung HC. Secondary neutropenia (SN) after autologous hematopoietic stem cell transplantation (AHSCT) in patients (pts) with lymphoma. Journal of Clinical Oncology. 30: 6552-6552. DOI: 10.1200/Jco.2012.30.15_Suppl.6552 |
0.371 |
|
| 2012 |
Fung HC, Alikhan M, Buckingham L, Maciejewski JJ, Karmali R, Christopherson KW, Rich ES, Venugopal P, Gregory SA, Nathan S. Engraftment Kinetics After Alimtuzumab-Based Allogeneic Stem Cell Transplant (SCT): Full Donor T-Cell Chimerism Did Not Predict for Acute Graft Versus Host Disease (GVHD) or CMV Reactivation Blood. 120: 4162-4162. DOI: 10.1182/Blood.V120.21.4162.4162 |
0.362 |
|
| 2012 |
Jagan S, Paganessi LA, Frank RR, Gezer S, Rizman A, Keller MC, Larson ML, Venugopal P, Gregory SA, Christopherson KW. Abstract 4668: Patient AML cells and AML cell lines are highly sensitive to CNDAC, the active form of sapacitabine Cancer Research. 72: 4668-4668. DOI: 10.1158/1538-7445.Am2012-4668 |
0.412 |
|
| 2012 |
Frank R, Jagan S, Paganessi L, McNulty M, Sumner D, Fung H, Gregory S, Christopherson K. Endothelial Progenitor Cell Mobilization in C57BL/6 Mice Following Treatment with Single Agent or Combination Neupogen (G-CSF), Plerixafor (AMD3100), and VEGF Biology of Blood and Marrow Transplantation. 18: S374. DOI: 10.1016/J.Bbmt.2011.12.458 |
0.325 |
|
| 2012 |
Frank R, Jagan S, Paganessi L, McNulty M, Sumner D, Fung H, Gregory S, Christopherson K. Effective Mobilization of Mesenchymal Stem Cells in C57BL/6 Mice Utilizing Single Agent Plerixafor (AMD3100) or in Combination with Neupogen (G-CSF) Biology of Blood and Marrow Transplantation. 18: S266. DOI: 10.1016/J.Bbmt.2011.12.184 |
0.35 |
|
| 2012 |
Fung HC, Tornatta J, McLeod B, Nathan S, Maciejewski J, Rich E, Karmali R, Jimenez A, Christopherson KW, Gregory SA. Despite the Use of the Combination of G-CSF and Plerixafor for Stem Cell Mobilization, One Third of the Patients with Lymphoma Were Still “Poor Mobilizer” Using the Criteria Recently Proposed by GITMO (< 2.0 X 106 CD 34 + Cells Per Kg in ≤ 3 Apheresis) Biology of Blood and Marrow Transplantation. 18. DOI: 10.1016/J.Bbmt.2011.12.175 |
0.43 |
|
| 2011 |
Jagan S, Paganessi LA, Gezer S, Rizman A, Rifai D, Keller MC, Larson ML, Venugopal P, Frame S, Christopherson KW. Comparison of cytarabine, mitoxantrone, and CNDAC in vitro treatment of AML bone marrow and peripheral blood cells. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 6588. PMID 28020141 DOI: 10.1200/Jco.2011.29.15_Suppl.6588 |
0.34 |
|
| 2011 |
Plaas A, Velasco J, Gorski DJ, Li J, Cole A, Christopherson K, Sandy JD. The relationship between fibrogenic TGFβ1 signaling in the joint and cartilage degradation in post-injury osteoarthritis. Osteoarthritis and Cartilage / Oars, Osteoarthritis Research Society. 19: 1081-90. PMID 21624477 DOI: 10.1016/J.Joca.2011.05.003 |
0.362 |
|
| 2011 |
Kidd S, Bueso-Ramos C, Jagan S, Paganessi LA, Boggio LN, Fung HC, Gregory SA, Christopherson KW. In vivo expansion of the megakaryocyte progenitor cell population in adult CD26-deficient mice. Experimental Hematology. 39: 580-590.e1. PMID 21291952 DOI: 10.1016/J.Exphem.2011.01.012 |
0.427 |
|
| 2011 |
Paganessi LA, Walker AL, Tan LL, Holmes I, Rich E, Fung HC, Christopherson KW. Effective mobilization of hematopoietic progenitor cells in G-CSF mobilization defective CD26-/- mice through AMD3100-induced disruption of the CXCL12-CXCR4 axis. Experimental Hematology. 39: 384-90. PMID 21168468 DOI: 10.1016/J.Exphem.2010.12.003 |
0.406 |
|
| 2011 |
Tornatta J, Maciejewski JJ, Nathan S, Mcleod B, Palaparthy S, Rich ES, Christopherson KW, Gregory SA, Fung HC. Efficacy of Plerixafor Administered At 5:00PM for Stem Cell Mobilization in Lymphoma and Myeloma Patients Undergoing Autologous Stem Cell Transplant, Blood. 118: 4061-4061. DOI: 10.1182/Blood.V118.21.4061.4061 |
0.436 |
|
| 2011 |
Frank RR, Jagan S, Paganessi LA, Larson ML, Karmali R, Venugopal P, Gregory SA, Christopherson KW. CD20, CD22, CD23, but Not CD37 Expression on CD19+ B-Cells Is Altered by Exogenous Factors in a Sub-Population of Chronic Lymphocytic Leukemia/Small Lymphocytic Leukemia (CLL/SLL) Patients, Blood. 118: 3685-3685. DOI: 10.1182/Blood.V118.21.3685.3685 |
0.367 |
|
| 2011 |
Paganessi LA, Frank RR, Jagan S, Karmali R, Li Y, Deng Y, Fhied CL, Borgia JA, Larson ML, Venugopal P, Gregory SA, Christopherson KW. Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Leukemia (SLL) Exhibit Altered Cytokine Protein Levels in Peripheral Blood Serum Blood. 118: 2646-2646. DOI: 10.1182/Blood.V118.21.2646.2646 |
0.402 |
|
| 2010 |
Yoo E, Jagan S, Palaparthy S, Enriquez MA, Samuels K, Walters S, Mieras E, Paganessi LA, Seong C, Rich ES, Fung HC, Christopherson KW. CD26 Inhibition Preferentially Enhances In Vitro Migration of G-CSF + Plerixafor (AMD3100) Mobilized PB as Compared to G-CSF Mobilized PB In Multiple Myeloma Autografts. Blood. 116: 3714-3714. DOI: 10.1182/Blood.V116.21.3714.3714 |
0.459 |
|
| 2010 |
Frank R, Jimenez H, Jagan S, Tan LL, Paganessi LA, Larson ML, Venugopal P, Gregory SA, Christopherson KW. Gain of CD20 Target Cell Surface Receptor Expression During Serum-Free Ex Vivo Culture of CD19+CD5+ B-Cells In a Sub-Population of Early Stage (Rai 0/1) Chronic Lymphocytic Leukemia Patients Blood. 116: 2000-2000. DOI: 10.1182/Blood.V116.21.2000.2000 |
0.416 |
|
| 2010 |
Paganessi LA, Tan LL, Jagan S, Frank R, Jimenez AM, Rich ES, Nathan S, Maciejewski J, Fung HC, Christopherson KW. Cytokine Treatment of CD34+ Cord Blood Cells with G-CSF, GM-CSF, or SCF During 48 Hours of Ex Vivo Culture Alters CD26/DPPIV Peptidase Activity and Subsequent Engraftment Into NSG Immunodeficient Mice. Blood. 116: 1460-1460. DOI: 10.1182/Blood.V116.21.1460.1460 |
0.445 |
|
| 2010 |
Usha L, Christopherson K, Rao G, Xu X. Abstract P4-05-04: Lack of the Effect of Mesenchymal Stem Cells on Breast Cancer Initiation and Growth in a Somatic Mouse Breast Cancer Model Cancer Research. 70. DOI: 10.1158/0008-5472.Sabcs10-P4-05-04 |
0.393 |
|
| 2009 |
Christopherson KW, Landay A. Liver X receptor alpha (LXRalpha) as a therapeutic target in chronic lymphocytic leukemia (CLL). Journal of Leukocyte Biology. 86: 1019-21. PMID 19875628 DOI: 10.1189/Jlb.0509295 |
0.44 |
|
| 2009 |
Frank R, Jagan S, Tan LL, Paganessi LA, Christopherson KW. Use of the CD26 Inhibitor Diprotin A (Ile-Pro-Ile) to Increase Mobilized Peripheral Blood Mononuclear Cell Adhesion and Migration. Blood. 114: 372-372. DOI: 10.1182/Blood.V114.22.372.372 |
0.468 |
|
| 2009 |
Paganessi L, Walker A, Fung H, Christopherson K. Co-Transplantation of Cord Blood with Wharton's Jelly Derived Umbilical Cord – Mesenchymal Stem Cell S (UC-MSC) Improves Short Term Myeloid Engraftment into NOD/SCID/IL-2Rγnull mice Biology of Blood and Marrow Transplantation. 15: 15-16. DOI: 10.1016/J.Bbmt.2008.12.045 |
0.351 |
|
| 2008 |
Bakhshi T, Zabriskie RC, Bodie S, Kidd S, Ramin S, Paganessi LA, Gregory SA, Fung HC, Christopherson KW. Mesenchymal stem cells from the Wharton's jelly of umbilical cord segments provide stromal support for the maintenance of cord blood hematopoietic stem cells during long-term ex vivo culture. Transfusion. 48: 2638-44. PMID 18798803 DOI: 10.1111/J.1537-2995.2008.01926.X |
0.371 |
|
| 2008 |
Paganessi LA, Gregory SA, Fung HC, Christopherson KW. CD26 Inhibitor Treated and CD26−/− Recipient Mice Exhibit Improved Transplant Efficiency as Quantitated by Increased Short-Term Homing and Long-Term Engraftment Blood. 112: 361-361. DOI: 10.1182/Blood.V112.11.361.361 |
0.385 |
|
| 2008 |
Paganessi LA, Walker AL, Gregory SA, Fung HC, Christopherson KW. Disruption of CXCR4 Utilizing AMD3100 Bypasses Mobilization Deficiency Exhibited by CD26−/− Mice and Results in Efficient Mobilization of Myeloid Progenitors Blood. 112: 3492-3492. DOI: 10.1182/Blood.V112.11.3492.3492 |
0.413 |
|
| 2008 |
Paganessi LA, Walker AL, Christopherson KW. Presence of Soluble CD26 Peptidase Activity in Human Serum Albumin (FlexBumin): Implications for Cell Freezing and Thawing Protocols during Transplantation Blood. 112: 3475-3475. DOI: 10.1182/Blood.V112.11.3475.3475 |
0.384 |
|
| 2008 |
Paganessi L, Gregory S, Fung H, Christopherson K. 72: Recipient Based Strategies for Improved Transplant Efficiency: CD26 Inhibitor Treated and CD26-/- Recipient Mice Exhibit Increased Short-Term Homing and Long-Term Engraftment of Hematopoietic Stem and Progenitor Cells Biology of Blood and Marrow Transplantation. 14: 29. DOI: 10.1016/J.Bbmt.2007.12.080 |
0.375 |
|
| 2007 |
Li Y, Yan J, De P, Chang HC, Yamauchi A, Christopherson KW, Paranavitana NC, Peng X, Kim C, Munugalavadla V, Munugulavadla V, Kapur R, Chen H, Shou W, Stone JC, et al. Rap1a null mice have altered myeloid cell functions suggesting distinct roles for the closely related Rap1a and 1b proteins. Journal of Immunology (Baltimore, Md. : 1950). 179: 8322-31. PMID 18056377 DOI: 10.4049/Jimmunol.179.12.8322 |
0.409 |
|
| 2007 |
Christopherson KW, Paganessi LA, Napier S, Porecha NK. CD26 inhibition on CD34+ or lineage- human umbilical cord blood donor hematopoietic stem cells/hematopoietic progenitor cells improves long-term engraftment into NOD/SCID/Beta2null immunodeficient mice. Stem Cells and Development. 16: 355-60. PMID 17610365 DOI: 10.1089/Scd.2007.9996 |
0.408 |
|
| 2007 |
Mehta SA, Christopherson KW, Bhat-Nakshatri P, Goulet RJ, Broxmeyer HE, Kopelovich L, Nakshatri H. Negative regulation of chemokine receptor CXCR4 by tumor suppressor p53 in breast cancer cells: implications of p53 mutation or isoform expression on breast cancer cell invasion. Oncogene. 26: 3329-37. PMID 17130833 DOI: 10.1038/Sj.Onc.1210120 |
0.347 |
|
| 2007 |
Jimenez A, Farhat MI, Gregory SA, Kassar M, Gimelfarb A, Batus M, Nangia J, Shah N, Venugopal P, Larson ML, Christopherson KW, Fung HC. Autologous (Auto) and Allogeneic (Allo) Stem Cell Transplantation (SCT) for Pateints (pts) with Advanced Chronic Lymphoctic Leukemia (CLL): A Comparative Study. Blood. 110: 5044-5044. DOI: 10.1182/Blood.V110.11.5044.5044 |
0.303 |
|
| 2007 |
Christopherson KW, Paganessi LA, Napier S, Porecha NK. CD26 Inhibition on CD34+ or Lineage− Human Umbilical Cord Blood Donor HSC/HPC Improves Long-Term Engraftment into NOD/SCID/Beta2null Immunodeficient Mice. Blood. 110: 4853-4853. DOI: 10.1182/Blood.V110.11.4853.4853 |
0.443 |
|
| 2007 |
Christopherson KW, Paganessi LA, Rhoades DR, Dillon HM, Gezer S, Larson ML, Fung HC, Gregory SA. Abnormally High Levels of Circulating CD34+CD38−, CD34+CD38+, and CD10+ Hematopoietic Stem and Progenitor Cells in the Peripheral Blood of B-Cell Chronic Lymphocytic Leukemia (B-CLL) Patients Suggest the Presence of Additional Therapeutic Target Cells. Blood. 110: 4711-4711. DOI: 10.1182/Blood.V110.11.4711.4711 |
0.449 |
|
| 2007 |
Kidd S, Bueso-Ramos CE, Paganessi LA, Fung H, Gregory S, Christopherson KW. In Vivo Expansion of Megakaryocyte Progenitors in CD26−/ − Mice: Implications for Novel Post-Transplant Therapeutics. Blood. 110: 1188-1188. DOI: 10.1182/Blood.V110.11.1188.1188 |
0.43 |
|
| 2006 |
Starnes T, Rasila KK, Robertson MJ, Brahmi Z, Dahl R, Christopherson K, Hromas R. The chemokine CXCL14 (BRAK) stimulates activated NK cell migration: implications for the downregulation of CXCL14 in malignancy. Experimental Hematology. 34: 1101-5. PMID 16863917 DOI: 10.1016/J.Exphem.2006.05.015 |
0.708 |
|
| 2006 |
Christopherson KW, Uralil SE, Porecha NK, Zabriskie RC, Kidd SM, Ramin SM. G-CSF- and GM-CSF-induced upregulation of CD26 peptidase downregulates the functional chemotactic response of CD34+CD38- human cord blood hematopoietic cells. Experimental Hematology. 34: 1060-8. PMID 16863912 DOI: 10.1016/J.Exphem.2006.03.012 |
0.453 |
|
| 2006 |
Porecha NK, English K, Hangoc G, Broxmeyer HE, Christopherson KW. Enhanced functional response to CXCL12/SDF-1 through retroviral overexpression of CXCR4 on M07e cells: implications for hematopoietic stem cell transplantation. Stem Cells and Development. 15: 325-33. PMID 16846371 DOI: 10.1089/Scd.2006.15.325 |
0.477 |
|
| 2006 |
Christopherson KW, Bakhshi T, Bodie S, Kidd S, Zabriskie R, Ramin S. Mesenchymal Stem Cells from the Wharton’s Jelly of Umbilical Cord Segments Support the Maintenance of Long Term Culture-Initiating Cells from Cord Blood. Blood. 108: 3650-3650. DOI: 10.1182/Blood.V108.11.3650.3650 |
0.433 |
|
| 2006 |
Bakhshi T, Bodie S, Kidd S, Zabriskie R, Ramin S, Christopherson K. Isolation of mesenchymal stem cells from the wharton's jelly of umbilical cord segments American Journal of Obstetrics and Gynecology. 195: S119. DOI: 10.1016/J.Ajog.2006.10.408 |
0.33 |
|
| 2005 |
Christopherson KW, Uralil SE, Kidd SM, Porecha NK, Zabriskie RC. Cytokine Induced Changes in the Hematopoietic Stem Cell Trafficking Regulatory Peptidase CD26. Blood. 106: 5220-5220. DOI: 10.1182/Blood.V106.11.5220.5220 |
0.479 |
|
| 2005 |
Broxmeyer H, Christopherson K, Hangoc G, Campbell T. 15. Augmentation of homing of cord blood stem cells Biology of Blood and Marrow Transplantation. 11: 933. DOI: 10.1016/J.Bbmt.2005.08.014 |
0.367 |
|
| 2004 |
Christopherson KW, Hangoc G, Mantel CR, Broxmeyer HE. Modulation of hematopoietic stem cell homing and engraftment by CD26. Science (New York, N.Y.). 305: 1000-3. PMID 15310902 DOI: 10.1126/Science.1097071 |
0.441 |
|
| 2004 |
Ramsey H, Christopherson K, Hromas R. Forced expression of AML1-AMP19, a fusion transcript generated from a radiation-associated t(19;21) leukemia, blocks myeloid differentiation. Leukemia Research. 28: 863-8. PMID 15203284 DOI: 10.1016/J.Leukres.2003.12.011 |
0.589 |
|
| 2004 |
Christopherson KW, Hromas RA. Endothelial chemokines in autoimmune disease. Current Pharmaceutical Design. 10: 145-54. PMID 14754394 DOI: 10.2174/1381612043453405 |
0.537 |
|
| 2004 |
Broxmeyer HE, Christopherson KW. Stromal cell derived factor-1/CXCL12, CXCR4 and CD26 in the mobilization and homing of hematopoietic stem and progenitor cells Current Medicinal Chemistry: Anti-Inflammatory and Anti-Allergy Agents. 3: 303-311. DOI: 10.2174/1568014043355249 |
0.361 |
|
| 2004 |
Vadhan-Raj S, Bueso-Ramos CE, Hangoc G, Christopherson K, Collard M, Broxmeyer H. Expansion of Bone Marrow (BM) Progenitors and Mobilization of Multilineage Progenitor Cells Associated with Once Per Cycle Administration of Long-Acting Growth Factors Neulasta and Aranesp with Chemotherapy (CT): Biology and Nature of Response. Blood. 104: 2905-2905. DOI: 10.1182/Blood.V104.11.2905.2905 |
0.421 |
|
| 2004 |
Christopherson KW, Porecha NK, Hangoc G, Broxmeyer HE. Enhanced Functional Response to CXCL12/SDF-1 through Retroviral Overexpression of CXCR4: Implications for Hematopoietic Stem & Progenitor Cell Homing and Engraftment. Blood. 104: 1198-1198. DOI: 10.1182/Blood.V104.11.1198.1198 |
0.505 |
|
| 2003 |
Christopherson KW, Cooper S, Hangoc G, Broxmeyer HE. CD26 is essential for normal G-CSF-induced progenitor cell mobilization as determined by CD26-/- mice. Experimental Hematology. 31: 1126-34. PMID 14585379 DOI: 10.1016/J.Exphem.2003.07.002 |
0.418 |
|
| 2003 |
Christopherson KW, Cooper S, Broxmeyer HE. Cell surface peptidase CD26/DPPIV mediates G-CSF mobilization of mouse progenitor cells. Blood. 101: 4680-6. PMID 12576320 DOI: 10.1182/Blood-2002-12-3893 |
0.482 |
|
| 2003 |
Christopherson KW, Hood AF, Travers JB, Ramsey H, Hromas RA. Endothelial induction of the T-cell chemokine CCL21 in T-cell autoimmune diseases. Blood. 101: 801-6. PMID 12393410 DOI: 10.1182/Blood-2002-05-1586 |
0.621 |
|
| 2002 |
Christopherson KW, Hangoc G, Broxmeyer HE. Cell surface peptidase CD26/dipeptidylpeptidase IV regulates CXCL12/stromal cell-derived factor-1 alpha-mediated chemotaxis of human cord blood CD34+ progenitor cells. Journal of Immunology (Baltimore, Md. : 1950). 169: 7000-8. PMID 12471135 DOI: 10.4049/Jimmunol.169.12.7000 |
0.461 |
|
| 2002 |
Christopherson KW, Campbell JJ, Travers JB, Hromas RA. Low-molecular-weight heparins inhibit CCL21-induced T cell adhesion and migration. The Journal of Pharmacology and Experimental Therapeutics. 302: 290-5. PMID 12065729 DOI: 10.1124/Jpet.302.1.290 |
0.608 |
|
| 2001 |
Christopherson KW, Campbell JJ, Hromas RA. Transgenic overexpression of the CC chemokine CCL21 disrupts T-cell migration. Blood. 98: 3562-8. PMID 11739157 DOI: 10.1182/Blood.V98.13.3562 |
0.62 |
|
| 2001 |
Christopherson K, Hromas R. Chemokine regulation of normal and pathologic immune responses. Stem Cells (Dayton, Ohio). 19: 388-96. PMID 11553847 DOI: 10.1634/Stemcells.19-5-388 |
0.61 |
|
| 2000 |
Robertson MJ, Williams BT, Christopherson K, Brahmi Z, Hromas R. Regulation of human natural killer cell migration and proliferation by the exodus subfamily of CC chemokines. Cellular Immunology. 199: 8-14. PMID 10675270 DOI: 10.1006/Cimm.1999.1601 |
0.649 |
|
| 1999 |
Christopherson K, Brahmi Z, Hromas R. Regulation of naïve fetal T-cell migration by the chemokines Exodus-2 and Exodus-3. Immunology Letters. 69: 269-73. PMID 10482362 DOI: 10.1016/S0165-2478(99)00099-1 |
0.631 |
|
| 1999 |
Hromas R, Broxmeyer HE, Kim C, Christopherson K, Hou YH. Isolation of ALP, a novel divergent murine CC chemokine with a unique carboxy terminal extension. Biochemical and Biophysical Research Communications. 258: 737-40. PMID 10329455 DOI: 10.1006/Bbrc.1999.0507 |
0.541 |
|
| 1999 |
Hromas R, Broxmeyer HE, Kim C, Nakshatri H, Christopherson K, Azam M, Hou YH. Cloning of BRAK, a novel divergent CXC chemokine preferentially expressed in normal versus malignant cells. Biochemical and Biophysical Research Communications. 255: 703-6. PMID 10049774 DOI: 10.1006/Bbrc.1999.0257 |
0.609 |
|
| Show low-probability matches. |